Home / Letter From The Editor (page 111)

Letter From The Editor

Letter from the Editor #617: OTC Meds for Diabetes, Hypertension and Cholesterol – You’ve Got to Be Kidding Me!

OTC Meds for Diabetes, Hypertension and Cholesterol – You’ve Got to Be Kidding! This week we have an interesting item (Item #3, Diabetes and Statin Meds May Become Available without a Prescription) about the FDA’s idea to make diabetes, cholesterol and hypertensive medications available over the counter. Their thought is …

Read More »

Editor’s Note DCMS #74: New Homerun Slides

We all know that diabetes has reached an epic level in this country and the prospects for improvement in the near future are not that great. Since patients are getting the disease sooner it is likely that they will also need increased care as the future approaches. This usually means …

Read More »

Editor’s Note #73: When Half of 12 is Not 6!

We have seen that many of our diabetes patients also have hypertension and or elevated lipids and are often referred to as suffering from cardiometabolic syndrome. Over the past couple of months, Stan Schwartz, MD, FACP, has been educating us on the diagnosis and treatment of this syndrome. He finishes …

Read More »

Editor’s Note: Ranolazine and A1c

Ranolazine is a medication used for the prevention of angina which also seems to have a positive effect on A1c. This makes it a very important drug for cardiometabolic treatment according to Stan Schwartz MD, FACP, Clinical Associate Professor of Medicine, U of Pa. Check out this week’s Homerun Slides …

Read More »